Definition | Symbol | Probe_Id | Entrez Gene ID | Mean 2log ratio | |
---|---|---|---|---|---|
Energy metabolism | |||||
Glutamate-ammonia ligase (glutamine synthetase) (GLUL), transcript variant 3, mRNA | GLUL | ILMN_1765208 | 2752 | 0.67 | a |
Runt-related transcription factor 1; translocated to, 1 (cyclin D-related) (RUNX1T1), transcript variant 3, mRNA | RUNX1T1 | ILMN_1710522 | 862 | 0.65 | a |
Peroxisome proliferator-activated receptor gamma, coactivator-related 1 (PPRC1), mRNA | PPRC1 | ILMN_1796210 | 23082 | 0.65 | b |
SLIT-ROBO Rho GTPase activating protein 2 (SRGAP2), transcript variant 1, mRNA | SRGAP2 | ILMN_1759549 | 23380 | 0.57 | b |
Pyruvate carboxylase (PC), nuclear gene encoding mitochondrial protein, transcript variant 3, mRNA | PC | ILMN_1736689 | 5091 | 0.44 | a |
FERM domain containing 6 (FRMD6), transcript variant 2, mRNA | FRMD6 | ILMN_2330787 | 122786 | 0.42 | b |
Solute carrier family 25, member 29 (SLC25A29), nuclear gene encoding mitochondrial protein, mRNA | SLC25A29 | ILMN_2350801 | 123096 | 0.40 | b |
Solute carrier family 25 (mitochondrial carrier, brain), member 14 (SLC25A14), nuclear gene encoding mitochondrial protein, transcript variant long, mRNA | SLC25A14 | ILMN_1743770 | 9016 | 0.39 | a |
Acyl-Coenzyme A dehydrogenase, C-2 to C-3 short chain (ACADS), nuclear gene encoding mitochondrial protein, mRNA | ACADS | ILMN_1795104 | 35 | −0.27 | b |
DNA replication helicase 2 homolog (yeast) (DNA2), mRNA | DNA2 | ILMN_2282959 | 1763 | −0.57 | b |
Protein kinase C, alpha binding protein (PRKCABP), mRNA | PRKCABP | ILMN_1708159 | 9463 | −0.67 | a |
Apolipoprotein O-like (APOOL), mRNA | APOOL | ILMN_1777483 | 139322 | −0.68 | a |
Acyl-CoA synthetase medium-chain family member 5 (ACSM5), mRNA | ACSM5 | ILMN_1801698 | 54988 | −0.71 | a |
Estrogen receptor 2 (ER beta) (ESR2), transcript variant b, mRNA | ESR2 | ILMN_2390457 | 2100 | −0.74 | a |
PREDICTED: coiled-coil domain containing 56 (CCDC56), misc RNA | CCDC56 | ILMN_1789786 | 28958 | −0.86 | a |
Component of oligomeric golgi complex 8 (COG8), mRNA | COG8 | ILMN_1725246 | 84342 | −1.09 | b |
Adhesion | |||||
Presenilin 1 (Alzheimer disease 3) (PSEN1), mRNA | PSEN1 | ILMN_1796669 | 5663 | 1.13 | a |
PREDICTED: p21 (CDKN1A)-activated kinase 2 (PAK2), mRNA | PAK2 | ILMN_1659878 | 5062 | 0.96 | a |
Reelin (RELN), transcript variant 1, mRNA | RELN | ILMN_1753005 | 5649 | 0.89 | b |
LIM and senescent cell antigen-like domains 1 (LIMS1), mRNA | LIMS1 | ILMN_2381037 | 3987 | 0.71 | b |
Dystonin (DST), transcript variant 1e, mRNA | DST | ILMN_1675992 | 667 | 0.70 | a |
Rap guanine nucleotide exchange factor (GEF) 1 (RAPGEF1), transcript variant 2, mRNA | RAPGEF1 | ILMN_1678799 | 2889 | 0.50 | a |
Protocadherin 9 (PCDH9), transcript variant 2, mRNA | PCDH9 | ILMN_2379626 | 5101 | 0.46 | b |
Phosphoglucomutase 5 (PGM5), mRNA | PGM5 | ILMN_2271149 | 5239 | 0.45 | b |
Periostin, osteoblast specific factor (POSTN), mRNA | POSTN | ILMN_1790761 | 10631 | 0.44 | b |
Claudin 15 (CLDN15), transcript variant 2, mRNA | CLDN15 | ILMN_1708267 | 24146 | 0.38 | a |
PREDICTED: p21 (CDKN1A)-activated kinase 2 (PAK2), mRNA | PAK2 | ILMN_1676385 | 5062 | 0.38 | a |
Polycystic kidney and hepatic disease 1 (autosomal recessive) (PKHD1), transcript variant 1, mRNA | PKHD1 | ILMN_1720034 | 5314 | −0.30 | b |
Cadherin, EGF LAG seven-pass G-type receptor 1 (flamingo homolog, Drosophila) (CELSR1), mRNA | CELSR1 | ILMN_1694482 | 9620 | −0.50 | b |
v-akt murine thymoma viral oncogene homolog 3 (protein kinase B, gamma) (AKT3), transcript variant 2, mRNA | AKT3 | ILMN_1733598 | 10000 | −0.59 | b |
Junction plakoglobin (JUP), transcript variant 2, mRNA | JUP | ILMN_2366864 | 3728 | −0.67 | a |
Myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 4 (MLLT4), transcript variant 3, mRNA | MLLT4 | ILMN_1746277 | 4301 | −0.77 | b |
Cadherin-like 24 (CDH24), transcript variant 1, mRNA | CDH24 | ILMN_1693928 | 64403 | −0.83 | a |
Rap guanine nucleotide exchange factor (GEF) 1 (RAPGEF1), transcript variant 1, mRNA | RAPGEF1 | ILMN_1695282 | 2889 | −0.93 | b |
Inflammation | |||||
Presenilin 1 (Alzheimer disease 3) (PSEN1), mRNA | PSEN1 | ILMN_1796669 | 5663 | 1.13 | a |
Cathepsin C (CTSC), transcript variant 2, mRNA | CTSC | ILMN_1689086 | 1075 | 0.78 | b |
Membrane-associated ring finger (C3HC4) 8 (MARCH8), transcript variant 6, mRNA | MARCH8 | ILMN_2341626 | 220972 | 0.78 | a |
Interleukin 7 receptor (IL7R), mRNA | IL7R | ILMN_2342579 | 3575 | 0.73 | a |
Interleukin 8 (IL8), mRNA | IL8 | ILMN_2184373 | 3576 | 0.66 | a |
Tumor necrosis factor receptor superfamily, member 13C (TNFRSF13C), mRNA | TNFRSF13C | ILMN_1731742 | 115650 | 0.63 | a |
Colony stimulating factor 1 (macrophage) (CSF1), transcript variant 4, mRNA | CSF1 | ILMN_1805930 | 1435 | 0.52 | b |
Epstein-Barr virus-induced 3 (EBI3), mRNA | EBI3 | ILMN_1802653 | 10148 | 0.51 | a |
Apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3F (APOBEC3F), transcript variant 1, mRNA | APOBEC3F | ILMN_1710726 | 200316 | 0.49 | b |
Neutrophil cytosolic factor 1 (NCF1), mRNA | NCF1 | ILMN_1697309 | 653361 | 0.38 | a |
Cathepsin C (CTSC), transcript variant 1, mRNA | CTSC | ILMN_2242463 | 1075 | 0.34 | b |
B and T lymphocyte associated (BTLA), transcript variant 1, mRNA | BTLA | ILMN_1778536 | 151888 | −0.19 | a |
Chemokine (C-X-C motif) receptor 5 (CXCR5), transcript variant 2, mRNA | CXCR5 | ILMN_2337931 | 643 | −0.42 | a |
Interleukin 1 receptor, type II (IL1R2), transcript variant 2, mRNA | IL1R2 | ILMN_1772131 | 7850 | −0.60 | b |
Lymphocyte transmembrane adaptor 1 (LAX1), mRNA | LAX1 | ILMN_1769782 | 54900 | −0.61 | a |
Serum amyloid A1 (SAA1), transcript variant 1, mRNA | SAA1 | ILMN_1701017 | 6288 | −0.68 | b |
Virus-induced signaling adapter (VISA), mRNA | VISA | ILMN_2131493 | 57506 | −0.69 | a |
Tumor necrosis factor (ligand) superfamily, member 12 (TNFSF12), transcript variant 2, mRNA | TNFSF12 | ILMN_1680003 | 8742 | −0.75 | a |
Serum amyloid A1 (SAA1), transcript variant 1, mRNA | SAA1 | ILMN_1808732 | 6288 | −1.29 | a |